Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.

Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, Liu CS, Salem R, Sangro B, Shuter B, Wang SC.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):401-7. doi: 10.1016/j.ijrobp.2010.08.015. Epub 2010 Oct 13.

PMID:
20950954
2.

(90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.

Camacho JC, Moncayo V, Kokabi N, Reavey HE, Galt JR, Yamada K, Kies DD, Williams RS, Kim HS, Schuster DM.

Radiographics. 2015 Sep-Oct;35(5):1602-18. doi: 10.1148/rg.2015140314. Epub 2015 Jul 31. Review.

PMID:
26230755
3.

[Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].

Antoch G, Mueller SP, Hamami M, Heusner TA, Ertle J, Hilgard P, Forsting M, Bockisch A.

Rofo. 2010 Aug;182(8):660-70. doi: 10.1055/s-0029-1245380. Epub 2010 Apr 19. Review. German.

PMID:
20405369
4.

[Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].

Hilgard P, Müller S, Hamami M, Sauerwein WS, Haberkorn U, Gerken G, Antoch G.

Z Gastroenterol. 2009 Jan;47(1):37-54. doi: 10.1055/s-2008-1028002. Epub 2009 Jan 20. Review. German.

PMID:
19156591
5.

A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.

Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS.

J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007.

PMID:
24461133
6.

PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.

Song YS, Paeng JC, Kim HC, Chung JW, Cheon GJ, Chung JK, Lee DS, Kang KW.

Medicine (Baltimore). 2015 Jun;94(23):e945. doi: 10.1097/MD.0000000000000945.

7.

Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.

Welsh JS, Kennedy AS, Thomadsen B.

Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S62-73. Review.

PMID:
16979443
8.

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):13-23.

PMID:
17448867
9.

Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.

Demirelli S, Erkilic M, Oner AO, Budak ES, Gunduz S, Ozgur O, Bozcuk H, Sindel HT, Boz A.

Nucl Med Commun. 2015 Apr;36(4):340-9. doi: 10.1097/MNM.0000000000000257.

PMID:
25563137
10.

Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.

Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari S, Negri A, Sposito C, Morosi C, Civelli E, Lanocita R, Camerini T, Bampo C, Bhoori S, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E.

Q J Nucl Med Mol Imaging. 2011 Apr;55(2):168-97. Review.

PMID:
21386789
11.

Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.

Kao YH, Hock Tan AE, Burgmans MC, Irani FG, Khoo LS, Gong Lo RH, Tay KH, Tan BS, Hoe Chow PK, Eng Ng DC, Whatt Goh AS.

J Nucl Med. 2012 Apr;53(4):559-66. doi: 10.2967/jnumed.111.097469. Epub 2012 Feb 17.

12.

Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.

Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Todica A, Bartenstein P, Hacker M, Haug AR.

J Nucl Med. 2015 Nov;56(11):1654-60. doi: 10.2967/jnumed.115.162685. Epub 2015 Aug 27.

13.

Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.

Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, Murthy R, Line BR, Van Echo DA.

Med Phys. 2003 Feb;30(2):199-203.

PMID:
12607837
14.

[Radioembolization with (90)Y-microspheres for liver tumors].

Rodríguez-Fraile M, Iñarrairaegui M.

Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):244-57. doi: 10.1016/j.remn.2015.03.004. Epub 2015 Apr 22. Spanish. No abstract available.

15.

SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.

Hamami ME, Poeppel TD, Müller S, Heusner T, Bockisch A, Hilgard P, Antoch G.

J Nucl Med. 2009 May;50(5):688-92. doi: 10.2967/jnumed.108.058347. Epub 2009 Apr 16.

16.
17.

Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.

Gnesin S, Canetti L, Adib S, Cherbuin N, Silva Monteiro M, Bize P, Denys A, Prior JO, Baechler S, Boubaker A.

J Nucl Med. 2016 Nov;57(11):1672-1678. Epub 2016 Jun 15.

PMID:
27307346
18.

Intraprocedural yttrium-90 positron emission tomography/CT for treatment optimization of yttrium-90 radioembolization.

Bourgeois AC, Chang TT, Bradley YC, Acuff SN, Pasciak AS.

J Vasc Interv Radiol. 2014 Feb;25(2):271-5. doi: 10.1016/j.jvir.2013.11.004.

PMID:
24461132
19.

Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.

Campbell JM, Wong CO, Muzik O, Marples B, Joiner M, Burmeister J.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):313-20. doi: 10.1016/j.ijrobp.2008.12.058.

PMID:
19362251
20.

Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.

Burgmans MC, Kao YH, Irani FG, Dames EL, Teo TK, Goh AS, Chow PK, Tay KH, Lo RH.

J Vasc Interv Radiol. 2012 Oct;23(10):1294-301. doi: 10.1016/j.jvir.2012.07.009. Epub 2012 Aug 24.

PMID:
22922039

Supplemental Content

Support Center